Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Evaluation of Chemotherapy-Induced Cardiotoxicity by Serial PET Myocardial Perfusion and Blood Flow Assessment - the PRECISION Trial

NCT05913999 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT05913999
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05913999 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Evaluation of Chemotherapy-Induced Cardiotoxicity by Serial PET Myocardial Perfusion and Blood Flow Assessment - the PRECISION Trial
Lead sponsor
University of California, Los Angeles
Phase
Observational
Overall status
Enrolling by invitation
Start date
June 1, 2023
Completion date
July 31, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, chemotherapeutic toxicity, coronary artery disease, coronary microvascular disease